Tata pharma and healthcare fund direct growth

Author: cwgf

August undefined, 2024

WebTata India Pharma & Healthcare Fund Direct Growth risk and rating. Home; Portfolio; Mutual Funds. Funds Home NEW; Analyst Ratings NEW; Factsheets NEW; Fund News NEW; Screen Funds NEW; Compare Funds NEW; Instant X-Ray NEW; Rank ETFs NEW; Equities. Equities Home NEW; Stocks ... WebApr 14, 2024 · SBI Healthcare Opportunities Fund Direct Growth Direct ... Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl Direct 18.4 5.75% -1.55% -0.65% ...

Tata India Pharma & HealthCare Fund - Direct Plan - Growth

WebMar 1, 2024 · The Tata India Pharma & Healthcare Fund Direct Growth has an AUM of 503.58 crores & has delivered CAGR of 14.31% in the last 5 years. The fund has an exit load of 0.25% and an expense ratio of 1.00%. WebApr 11, 2024 · Tata India Pharma & Healthcare Fund Direct Growth - Latest NAV ₹18.4528. Detailed analysis & complete track record of Tata India Pharma & Healthcare Fund Direct … simon weyrer

INDIA PHARMA & HEALTHCARE FUND

WebTata India Pharma & HealthCare Fund Direct Growth - Get latest NAV, SIP Returns & Rankings, Ratings, Fund Performance, Portfolio, Expense Ratio, Holding Analysis, and … WebApr 13, 2024 · Tata India Pharma & Healthcare Fund Direct Growth: Category : Sector - Healthcare Distribution Type : Growth Structure : Open Ended: Latest NAV : 18.3779: NAV Date : Apr 13, 2024: Tata India Pharma & Healthcare Fund … WebTata India Pharma & Healthcare Fund Direct Growth risk and rating. Home; Portfolio; Mutual Funds. Funds Home NEW; Analyst Ratings NEW; Factsheets NEW; Fund News NEW; … simon wey meaning

Tata India Pharma & Healthcare Fund-Direct Plan-Growth

WebJan 6, 2024 · The Net Asset Value is the per share market value of a mutual fund scheme. It is obtained by dividing the difference between the firm's total assets and liabilities by the number of outstanding units in the fund. Tata India Pharma & Healthcare Fund Direct Growth NAV calculation: NAV: (Assets - Liabilities)/ Total Number of Outstanding Units WebSearch Quotes, News, Mutual Fund NAVs ... ... simon whaby arrestWebMar 23, 2024 · Tata India Pharma & HealthCare Fund Direct-Growth is a Equity mutual fund scheme from Tata Mutual Fund. This scheme was launched on Invalid date and is … simon whaby helf for court

"WebCheck portfolio overview & analysis for Tata India Pharma And Healthcare Fund Direct Growth. Know more about asset allocation, sector allocation, list of stocks bought/sold, … " - Tata pharma and healthcare fund direct growth

Tata pharma and healthcare fund direct growth

WebApr 13, 2024 · Apart from the US, global emerging markets, domestic Indian market & also medical tourism are the growth drivers for this sector. Tata India Pharma & Healthcare … WebCheck portfolio overview & analysis for Tata India Pharma And Healthcare Fund Direct Growth. Know more about asset allocation, sector allocation, list of stocks bought/sold, historical data, and more.

Did you know?

WebGet complete details on NAV, performance, scheme objective, regular and direct plan AUMs, Returns, Minimum SIP investment amount, benchmark, fund manager performance, Tata … WebTata India Pharma & HealthCare Fund Direct-Growth Fund Key Highlights 1. Current NAV: The Current Net Asset Value of the Tata India Pharma & HealthCare Fund - Direct Plan as …

WebMar 27, 2024 · Tata India Pharma & HealthCare Fund - Direct Plan - Rediff Money - India's leading finance site for latest share prices, mutual funds, nifty futures and options, ... Tata …

WebTata Digital India Fund Direct Growth - Get latest NAV, SIP Returns & Rankings, Ratings, Fund Performance, Portfolio, Expense Ratio, Holding Analysis, and Peers. ... Tata India Pharma … WebGet detailed Portfolio analysis for Tata India Pharma & Heathcare Fund. Check detailed stocks and debt portfolio holding, changes in portfolio, list of stocks bought/sold, risk analysis of debt ...

WebGet the latest Tata India Pharma & Healthcare Fund Direct Growth (TATA_INDI_PHAR_WGSTAL) real-time quote, historical performance, charts, and other …

WebLearn about Tata India Pharma & Healthcare Fund Direct Growth with our data and independent analysis including NAV, star rating, portfolio, detailed portfolio, performance, … simon whaleyWebApr 6, 2024 · Tata India Pharma & HealthCare Fund Regular Growth - Get latest NAV, SIP Returns & Rankings, Ratings, Fund Performance, Portfolio, Expense Ratio, Holding … simon whalley persimmonWebPortfolio for Tata India Pharma & Healthcare Fund Direct Growth along with asset allocation, stock style, sector and region exposure, ... INVESCO ITI JM KOTAK LIC LNT … simon whale linkedinWebMar 17, 2024 · Tata India Pharma & Healthcare Fund - Direct Plan-Growth. This fund was launched on 28 December 2015. It is an open-ended Sectoral-Pharma mutual fund scheme from Tata Mutual Fund. simon whaley writerWebBenchmark. Composite Benchmark of 65% S&P BSE 200 + 15% CRISIL Short Term Bond Index + 20% iComdex Composite Index (Total Return variant of the index (TRI) will be used for performance comparison). NAV. (as on 10 Apr 2024) 17.1784. Know More Invest now. simon whabyWebGet the latest Tata India Pharma & Healthcare Fund Direct Growth (TATA_INDI_PHAR_WGSTAL) real-time quote, historical performance, charts, and other financial information to help you make more ... simon whale kerfuffleWebApr 6, 2024 · Tata India Pharma & Healthcare Fund-Direct Plan-Growth is a Equity scheme that has given 9.31% returns since inception. Get the latest information related to the fund including NAV, star rating, and detailed portfolio. simon whalley jones homes